What do we know and do not know about vitamin D?: A causal association between vitamin D receptor genetic polymorphism and hypertension

Journal of Clinical Hypertension

Volumn 16, Issue 9, 2014, Pages 627-628

  Solak, Yalcin ^a   Covic, Adrian ^b   Kanbay, Mehmet ^c  

^a Karaman State Hospital   (Turkey)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL 24 HYDROXYLASE; GLUCOSE; TRIACYLGLYCEROL; VITAMIN D; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

BLOOD PRESSURE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; NOTE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE;

ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL;

EID: 84907948731     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12383     Document Type: Note

References (12)

1. Jia J, Shen C, Mao L, et al. Vitamin D receptor genetic polymorphism is significantly associated with the decreased risk of hypertension in Chinese Han population. J Clin Hypertens (Greenwich). inpress.
2. Zhou TB, Jiang ZP, Lin ZJ, Su N. Association of vitamin D receptor gene polymorphism with the risk of systemic lupus erythematosus. J Recept Signal Transduct Res. 2014 May 19:1-5. [Epub ahead of print].
3. Ou C, Zhao HL, Zhu B, et al. Association of vitamin D receptor gene polymorphism with the risk of renal cell carcinoma: a meta-analysis. J Recept Signal Transduct Res. 2014 May 19:1-6 [Epub ahead of print].
4. Li S, Xu H, Li SC, et al. Vitamin D receptor rs2228570 polymorphism and susceptibly to ovarian cancer: a meta-analysis. Tumour Biol. 2014;35:1319-1322.
5. Christakos S, Dhawan P, Shen Q, et al. New insights into the mechanisms involved in the pleiotropic actions of 1, 25dihydroxyvitamin D3. Ann N Y Acad Sci. 2006;1068:194-203.
6. Rostand SG. Vitamin D deficiency in the pathogenesis of hypertension: still an unsettled question. Curr Hypertens Rep. 2014;16:464.
7. Carbone F, Mach F, Vuilleumier N, Montecucco F. Potential pathophysiological role for the vitamin D deficiency in essential hypertension. World J Cardiol. 2014;6:260-276.
8. Kunutsor SK, Burgess S, Munroe PB, Khan H. Vitamin D and high blood pressure: causal association or epiphenomenon? Eur J Epidemiol. 2014;29:1-14.
9. Swapna N, Vamsi UM, Usha G, Padma T. Risk conferred by FokI polymorphism of vitamin D receptor (VDR) gene for essential hypertension. Indian J Hum Genet. 2011;17:201-206.
10. Wang L, Ma J, Manson JE, et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur J Nutr. 2013;52:1771-1779.
11. He JL, Scragg RK. Vitamin D, parathyroid hormone, and blood pressure in the National Health and Nutrition Examination Surveys. Am J Hypertens. 2011;24:911-917.
12. Snijder MB, Lips P, Seidell JC, et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med. 2007;261:558-565.